Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
Public ClinicalTrials.gov record NCT01056341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Controlled, Multidose, Multicentre, Adaptive Phase II/III Study in Infants With Proliferating Infantile Hemangiomas (IHs) Requiring Systemic Therapy to Compare 4 Regimens of Propranolol (1 or 3 mg/kg/Day for 3 or 6 Months) to Placebo (Double Blind).
Study identification
- NCT ID
- NCT01056341
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Pierre Fabre Dermatology
- Industry
- Enrollment
- 512 participants
Conditions and interventions
Conditions
Interventions
- Propranolol Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 35 Days to 150 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2009
- Primary completion
- Apr 30, 2012
- Completion
- Oct 31, 2013
- Last update posted
- Dec 9, 2015
2010 – 2013
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California | Irvine | California | 92697-1385 | — |
| Lucile Packard Children's Hospital | Redwood City | California | 94063-5334 | — |
| Rady Children's Hospital | San Diego | California | 92123 | — |
| Miami Children's Hospital | Miami | Florida | 33155 | — |
| Children's Memorial Hospital | Chicago | Illinois | 60614 | — |
| Cardinal Glennon Children's Hospital | St Louis | Missouri | 63104 | — |
| State University of NY | Brooklyn | New York | 11203 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239 | — |
| Dell Children's Medical center | Austin | Texas | 78723 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01056341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01056341 live on ClinicalTrials.gov.